BAYER AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.16 EUR | -0.15% |
|
-0.82% | -22.20% |
| Jul. 02 | Cartesian Therapeutics, Inc. Appoints Kemal Malik to its Board of Directors | CI |
| Jun. 28 | Borse Frankfurt-News: Uncertainty ahead of French election (Bond Trading) | DP |
Presenter SpeechMatthias Berninger (Executives)Good afternoon. Good evening, everybody. Thank ...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
2024-08-06
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
26.16
EUR
Average target price
36.18
EUR
Spread / Average Target
+38.28%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -22.20% | 27.83B | |
| +56.89% | 823B | |
| +39.52% | 627B | |
| -6.55% | 353B | |
| +7.92% | 295B | |
| +13.74% | 239B | |
| +13.83% | 220B | |
| -0.49% | 219B | |
| +7.94% | 167B | |
| -2.57% | 159B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Transcript : Bayer Aktiengesellschaft - Special Call
